Challenges in the Pharmacogenomic Annotation of Whole Genomes

Russ B. Altman, Michelle Whirl‐Carrillo, Teri E. KleinClinical 2013 · DOI

Abstract

Next-generation sequencing technologies have enabled the sequencing of an entire genome for less than $4,000. With access to all the genetic variation in an individual, our task will be to use this information to assess the genetic influences on drug efficacy, toxicity, and dosage. Clinical Pharmacology & Therapeutics (2013); 94 2, 211–213. doi:10.1038/clpt.2013.111
BibTeX
@inproceedings{altman2013challenges,
  author = {Russ B. Altman and Michelle Whirl‐Carrillo and Teri E. Klein},
  title = {{Challenges in the Pharmacogenomic Annotation of Whole Genomes}},
  booktitle = {Clinical},
  year = {2013},
  doi = {10.1038/clpt.2013.111},
}

Loading related content...

Figure